OpenURL Connection Search

Select item for more details and to access through your institution.

Phase II Multicenter Study of Docetaxel and Bevacizumab With or Without Trastuzumab as First-Line Treatment for Patients With Metastatic Breast Cancer.
Published in:
Clinical Breast Cancer, 2014, v. 14, n. 3, p. 161, doi. 10.1016/j.clbc.2013.12.003
By:
- Schwartzberg, Lee S.;
- Badarinath, Suprith;
- Keaton, Mark R.;
- Childs, Barrett H.
Publication type:
Article
Larotrectinib versus Prior Therapies in Tropomyosin Receptor Kinase Fusion Cancer: An Intra-Patient Comparative Analysis.
Published in:
Cancers, 2020, v. 12, n. 11, p. 3246, doi. 10.3390/cancers12113246
By:
- Italiano, Antoine;
- Nanda, Shivani;
- Briggs, Andrew;
- Garcia-Foncillas, Jesus;
- Lassen, Ulrik;
- Vassal, Gilles;
- Kummar, Shivaani;
- van Tilburg, Cornelis M.;
- Hong, David S.;
- Laetsch, Theodore W.;
- Keating, Karen;
- Reeves, John A.;
- Fellous, Marc;
- Childs, Barrett H.;
- Drilon, Alexander;
- Hyman, David M.
Publication type:
Article
Addition of bevacizumab to three docetaxel regimens as adjuvant therapy for early stage breast cancer.
Published in:
2013
By:
- Yardley, Denise A.;
- Hart, Lowell;
- Waterhouse, David;
- Whorf, Robert;
- Drosick, D. Randolph;
- Murphy, Patrick;
- Badarinath, Suprith;
- Daniel, Brooke R.;
- Childs, Barrett H.;
- Burris, Howard
Publication type:
Report
High-dose chemotherapy with stem cell rescue as initial therapy for anaplastic oligodendroglioma: Long-term follow-up.
Published in:
Neuro-Oncology, 2006, v. 8, n. 2, p. 183, doi. 10.1215/15228517-2005-009
By:
- Abrey, Lauren E.;
- Childs, Barrett H.;
- Paleologos, Nina;
- Kaminer, Lynne;
- Rosenfeld, Steven;
- Salzman, Donna;
- Finlay, Jonathan L.;
- Gardner, Sharon;
- Peterson, Kendra;
- Hu, Wendy;
- Swinnen, Lode;
- Bayer, Robert;
- Forsyth, Peter;
- Stewart, Douglas;
- Smith, Anne M.;
- Macdonald, David R.;
- Weaver, Susan;
- Ramsay, David A.;
- Nimer, Stephen D.;
- DeAngelis, Lisa M.
Publication type:
Article
Feasibility of Combining the Phosphatidylinositol 3-Kinase Inhibitor Copanlisib With Rituximab-Based Immunochemotherapy in Patients With Relapsed Indolent B-cell Lymphoma.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, n. 11, p. e886, doi. 10.1016/j.clml.2021.06.021
By:
- Matasar, Matthew J.;
- Dreyling, Martin;
- Leppä, Sirpa;
- Santoro, Armando;
- Pedersen, Michael;
- Buvaylo, Viktoriya;
- Fletcher, Monique;
- Childs, Barrett H.;
- Zinzani, Pier Luigi
Publication type:
Article
Model‐Based Benefit/Risk Analysis for the Copanlisib Intermittent Dosing Regimen.
Published in:
Clinical Pharmacology & Therapeutics, 2024, v. 115, n. 5, p. 1092, doi. 10.1002/cpt.3173
By:
- Morcos, Peter N.;
- Moss, Jonathan;
- Veasy, Josh;
- Hiemeyer, Florian;
- Childs, Barrett H.;
- Garmann, Dirk
Publication type:
Article
A phase I pharmacokinetic study of copanlisib in Chinese patients with relapsed indolent non-Hodgkin lymphoma.
Published in:
Cancer Chemotherapy & Pharmacology, 2022, v. 89, n. 6, p. 825, doi. 10.1007/s00280-022-04417-3
By:
- Liu, Weiping;
- Ping, Lingyan;
- Xie, Yan;
- Sun, Yingli;
- Du, Tingting;
- Niu, Yi;
- Cisternas, Galia;
- Huang, Funan;
- Garcia-Vargas, Jose;
- Childs, Barrett H.;
- Mehra, Aruna;
- Reschke, Susanne;
- Wang, Xiaopei;
- Song, Yuqin;
- Zhu, Jun
Publication type:
Article
A multicenter phase II study of docetaxel, oxaliplatin, and bevacizumab in first-line therapy for unresectable locally advanced or metastatic non-squamous cell histology non-small-cell lung cancer (NSCLC)
Published in:
2013
By:
- Raez, Luis E;
- Santos, Edgardo S;
- Webb, R Timothy;
- Wade, James;
- Brito, Roger A;
- Karr, Melissa;
- Kennah, Andra;
- Childs, Barrett H
Publication type:
Journal Article
Copanlisib population pharmacokinetics from phase I–III studies and exposure–response relationships in combination with rituximab.
Published in:
CPT: Pharmacometrics & Systems Pharmacology, 2023, v. 12, n. 11, p. 1666, doi. 10.1002/psp4.13000
By:
- Morcos, Peter N.;
- Moss, Jonathan;
- Austin, Rupert;
- Hiemeyer, Florian;
- Zinzani, Pier Luigi;
- Beckert, Vita;
- Mongay Soler, Lidia;
- Childs, Barrett H.;
- Garmann, Dirk
Publication type:
Article
Safety and antitumor activity of copanlisib in Japanese patients with relapsed/refractory indolent non-Hodgkin lymphoma: a phase Ib/II study.
Published in:
International Journal of Hematology, 2023, v. 117, n. 1, p. 100, doi. 10.1007/s12185-022-03455-0
By:
- Fukuhara, Noriko;
- Maruyama, Dai;
- Hatake, Kiyohiko;
- Nagai, Hirokazu;
- Makita, Shinichi;
- Kamezaki, Kenjiro;
- Uchida, Toshiki;
- Kusumoto, Shigeru;
- Kuroda, Junya;
- Iriyama, Chisako;
- Yanada, Masamitsu;
- Tsukamoto, Norifumi;
- Suehiro, Youko;
- Minami, Hironobu;
- Garcia-Vargas, Jose;
- Childs, Barrett H.;
- Yasuda, Masanobu;
- Masuda, Shigeo;
- Tsujino, Toshiaki;
- Terao, Yui
Publication type:
Article
Model‐informed approach to support pediatric dosing for the pan‐PI3K inhibitor copanlisib in children and adolescents with relapsed/refractory solid tumors.
Published in:
CTS: Clinical & Translational Science, 2023, v. 16, n. 7, p. 1197, doi. 10.1111/cts.13523
By:
- Morcos, Peter N.;
- Schlender, Jan;
- Burghaus, Rolf;
- Moss, Jonathan;
- Lloyd, Adam;
- Childs, Barrett H.;
- Macy, Margaret E.;
- Reid, Joel M.;
- Chung, John;
- Garmann, Dirk
Publication type:
Article
Cytogenetic and morphological abnormalities in paroxysmal nocturnal haemoglobinuria.
Published in:
British Journal of Haematology, 2001, v. 115, n. 2, p. 360, doi. 10.1046/j.1365-2141.2001.03113.x
By:
- Araten, David J.;
- Swirsky, David;
- Karadimitris, Anastasios;
- Notaro, Rosario;
- Nafa, Khedoudja;
- Bessler, Monica;
- Thaler, Howard T.;
- Castro-Malaspina, Hugo;
- Childs, Barrett H.;
- Boulad, Farid;
- Weiss, Mark;
- Anagnostopoulos, Nikolaos;
- Kutlar, Abdullah;
- Savage, David G.;
- Maziarz, Richard T.;
- Jhanwar, Suresh;
- Luzzatto, Lucio
Publication type:
Article

Found: 12